Cargando…

Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound

Detalles Bibliográficos
Autores principales:	Barnhoorn, Marieke C, Storm, Bert N, de Boer, Nanne K, van der Voorn, Michael M P J A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376121/ https://www.ncbi.nlm.nih.gov/pubmed/33999201 http://dx.doi.org/10.1093/ibd/izab102

Ejemplares similares

Azathioprine: Tuberculous perihepatic abscess and myelotoxicity: case report
Publicado: (2021)

Azathioprine/infliximab/mesalazine: Coronavirus disease-19: case report
Publicado: (2020)

Predicted expression of genes involved in the thiopurine metabolic pathway and azathioprine discontinuation due to myelotoxicity
por: Daniel, Laura L., et al.
Publicado: (2022)

Association of thiopurine S-methyltransferase and NUDT15 polymorphisms with azathioprine-induced myelotoxicity in Chinese patients with rheumatological disease
por: Su, Song-Sen, et al.
Publicado: (2020)

Regulatory filing strategy for generic mesalazine modified release formulations
por: Gupta, Sandeep K.
Publicado: (2011)

Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn’s disease patients
por: de Souza, Gláucio Silva, et al.
Publicado: (2013)

Azathioprine is More Effective than Mesalazine at Preventing Recurrent Bowel Obstruction in Patients with Ileocecal Crohn’s Disease
por: Vidigal, Fernando Mendonça, et al.
Publicado: (2014)

Rare gene variants in a patient with azathioprine-induced lethal myelosuppression
por: Yang, Xiaoxue, et al.
Publicado: (2017)

The Clinical Efficacy of Azathioprine in Korean Patients with Atopic Dermatitis
por: Lee, Hemin, et al.
Publicado: (2015)

Azathioprine treatment in two children with Henoch–Schönlein purpura nephritis
por: Melikoğlu, Meltem A., et al.
Publicado: (2017)

Genetic differences in susceptibility to chemically induced myelotoxicity and leukemia.
por: Nebert, D W
Publicado: (1981)

Stem cell assays in the evaluation of myelotoxicity
por: Mangalik, Aroop, et al.
Publicado: (1981)

Assessment of myelotoxicity caused by environmental chemicals.
por: Boorman, G A, et al.
Publicado: (1982)

Evaluation of Myelotoxicity in Dietary Restricted Rats
por: Miyata, Hiroto, et al.
Publicado: (2009)

C-reactive protein levels and prevalence of leukopenia in patients with inflammatory bowel disease treated with azathioprine and/or mesalazine: a real-life study
por: dos Santos, Rejani Cristine Faustino, et al.
Publicado: (2022)

Mesalazine-induced renal calculi
por: Jacobsson, Henrik, et al.
Publicado: (2013)

Chlorella sorokiniana Extract Prevents Cisplatin-Induced Myelotoxicity In Vitro and In Vivo
por: Lin, Shyh-Horng, et al.
Publicado: (2020)

Prevention of benzene-induced myelotoxicity by nonsteroidal anti-inflammatory drugs.
por: Kalf, G F, et al.
Publicado: (1989)

Analytical approaches to the study of the disposition of myelotoxic agents.
por: Rickert, D E, et al.
Publicado: (1981)

Successful Treatment of Glycine-Receptor-Antibody-Mediated Progressive Encephalomyelitis with Rigidity and Myoclonus by Combining Steroids and Azathioprine
por: Lee, Eung-Joon, et al.
Publicado: (2019)

Recurrent Pregnancy-Related Pure Red Cell Aplasia Responsive to Combined Corticosteroid and Azathioprine Therapy: A Management Dilemma
por: Rao, Ashwin, et al.
Publicado: (2020)

Mesalazine-induced myocarditis: a case report
por: Radhakrishnan, Shiva T., et al.
Publicado: (2018)

Mesalazine-induced myopericarditis: a case report
por: Shergill, Simran
Publicado: (2020)

Analysis of clinical characteristics of mesalazine-induced cardiotoxicity
por: Chen, Junyu, et al.
Publicado: (2022)

Mesalazine-induced myopericarditis: a case series
por: Andrei, Valentina, et al.
Publicado: (2023)

Correction of Linezolid-Induced Myelotoxicity After Switch to Tedizolid in a Patient Requiring Suppressive Antimicrobial Therapy for Multidrug-Resistant Staphylococcus epidermidis Prosthetic-Joint Infection
por: Ferry, Tristan, et al.
Publicado: (2018)

Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose
por: Yin, Dandan, et al.
Publicado: (2017)

Infliximab treatment in a paediatric patient with ulcerative colitis, who developed acute pancreatitis due to azathioprine during follow-up
por: Basturk, Ahmet, et al.
Publicado: (2017)

An unusual adverse event of azathioprine: Cutaneous small vessel vasculitis
por: Hanai, Shunichiro, et al.
Publicado: (2021)

Myocarditis Related to the Use of Mesalazine
por: Kyriakou, Michaela, et al.
Publicado: (2023)

Importance of Starting Age for Myelotoxicity Study in Dietary Restricted Rats
por: Asanuma, Fumiko, et al.
Publicado: (2009)

Evaluation of Short-term Myelotoxicity Study in Dietary Reduced Rats
por: Asanuma, Fumiko, et al.
Publicado: (2010)

Azathioprine Hypersensitivity Syndrome: Two Cases of Febrile Neutrophilic Dermatosis Induced by Azathioprine
por: Aleissa, Majed, et al.
Publicado: (2017)

Azathioprine induced cholestatic hepatitis
por: Moses, Viju, et al.
Publicado: (2011)

Azathioprine-Induced Hypersensitivity Vasculitis
por: Sangiorgio, Michael, et al.
Publicado: (2023)

Intratibial injection of an anti-doxorubicin monoclonal antibody prevents drug-induced myelotoxicity in mice.
por: Morelli, D., et al.
Publicado: (1997)

Mesalazine-induced myopericarditis in a patient with ulcerative colitis
por: Asadi, Jalal, et al.
Publicado: (2017)

Severe Lupus Myocarditis Preceded by Mesalazine-induced Lupus
por: Yamashita, Mai, et al.
Publicado: (2022)

Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
por: van Liere, Elsa L. S. A., et al.
Publicado: (2021)

Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients()
por: Vivian, Analú, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_384bqbe8rknouh2umed4j2140r